Table 1.

Antigen-specific T-cell responses following chemoradiotherapy

PatientHLA-ATumor-specific antigens
A2402A0201LY6KTTKIMP3CDCA1TOMM34HIG2
1*
2*++++
3*++
4*
5*+
6*
7*
8*
9*
10*++++
11**
12*
13*
14*
15*+++
16*++

NOTE: *, HLA-A allele type in the patients with ESCC receiving chemotherapy; +, the positive T-cell responses specific for the indicated antigens evaluated by ELISPOT assay in patients' peripheral blood leucocytes following chemoradiotherapy.